ArticleCommunications chemistry2025
Domain adaptable language modeling of chemical compounds identifies potent pathoblockers for Pseudomonas aeruginosa.
Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- ADMET-XSpec: A Tool for Systematic Cross-Species Data Integration in ADMET Prediction.Chemical research in toxicology · 2026Article
- DCPM-ADMET: fusion of dual-component pre-trained model and molecular fingerprints to enhance drug ADMET properties prediction.Journal of cheminformatics · 2026Article
- Collision-free morgan fingerprints: a principled approach to enhance machine learning performance and interpretability in chemistry.Journal of cheminformatics · 2026Article
- Artificial intelligence drives the identification and screening of novel antibiotics and antimicrobial peptides.Briefings in bioinformatics · 2026Review
- Epidemiological investigation and clinical characteristics study of orthopedic infections caused by Aeromonas in the southeast coastal region from 2018 to 2024.BMC infectious diseases · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computational techniques for predicting molecular properties are emerging as key components for streamlining drug development, optimizing time and financial investments. Here, we introduce ChemLM, a transformer language model for this task. ChemLM leverages self-supervised domain adaptation on chemical molecules to enhance its predictive performance. Within the framework of ChemLM, chemical compounds are conceptualized as sentences composed of distinct chemical 'words', which are employed for training a specialized chemical language model. On the standard benchmark datasets, ChemLM either matched or surpassed the performance of current state-of-the-art methods. Furthermore, we evaluated the effectiveness of ChemLM in identifying highly potent pathoblockers targeting Pseudomonas aeruginosa (PA), a pathogen that has shown an increased prevalence of multidrug-resistant strains and has been identified as a critical priority for the development of new medications. ChemLM demonstrated substantially higher accuracy in identifying highly potent pathoblockers against PA when compared to state-of-the-art approaches. An intrinsic evaluation demonstrated the consistency of the chemical language model's representation concerning chemical properties. The results from benchmarking, experimental data and intrinsic analysis of the ChemLM space confirm the wide applicability of ChemLM for enhancing molecular property prediction within the chemical domain.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.